Ketamine for Sedation in Severe Traumatic Brain Injury
Status:
SUSPENDED
Trial end date:
2027-06-30
Target enrollment:
Participant gender:
Summary
This protocol is for an open-label randomized trial evaluating the safety of using ketamine in combination with propofol for sedation versus the standard of care analgosedation in patients admitted to the intensive care unit with severe traumatic brain injury.
Phase:
PHASE4
Details
Lead Sponsor:
Henry M. Jackson Foundation for the Advancement of Military Medicine
Collaborators:
Brooke Army Medical Center Uniformed Services University of the Health Sciences